Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Acta Physiol Scand ; 169(3): 237-47, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10886038

ABSTRACT

After abdominal surgery, luminal HCl fails to induce duodenal contractions in anaesthetized rats. Elevated tissue levels of nitric oxide (NO) and prostaglandins possibly contribute to this observation. The aim of this study was to compare the effects of luminal capsaicin (1.2 mg mL-1), ethanol (15%) and high partial pressure of CO2 (>250 mmHg) with those of HCl (10 mM) in anaesthetized rats. Motility (intraluminal pressure), mucosal permeability [blood-to-lumen clearance of 51Cr-EDTA (51Chromium-labelled ethylenediaminetetraacetate)] and duodenal mucosal bicarbonate secretion (DMBS) were recorded. Three groups of animals were studied: (1) controls, (2) pretreatment with the NO synthase inhibitor N-nitro-L-arginine-methyl-ester (L-NAME) and (3) pretreatment with the cyclo-oxygenase inhibitor indomethacin. Neither capsaicin, ethanol, CO2 nor HCl induced duodenal contractions or affected DMBS in control rats. However, L-NAME induced duodenal contractions that were augmented by capsaicin, ethanol and HCl, but not by CO2. Indomethacin also induced contractions that were reversibly diminished by capsaicin and HCl, but not by ethanol or CO2. Significant increases in mucosal permeability occurred during ethanol perfusion in indomethacin- and L-NAME pretreated rats. In conclusion, NO probably plays a key role in preventing duodenal contractions in response to luminally HCl, capsaicin and ethanol. The HCl-induced effect on motility appears to be independent of CO2 and is not caused by alteration in mucosal integrity.


Subject(s)
Duodenum/drug effects , Gastrointestinal Motility/drug effects , Muscle Contraction/drug effects , Nitric Oxide/pharmacology , Animals , Arginine/metabolism , Bicarbonates/metabolism , Capsaicin/administration & dosage , Carbon Dioxide/administration & dosage , Chromium Radioisotopes , Crosses, Genetic , Edetic Acid/pharmacokinetics , Ethanol/administration & dosage , Hydrochloric Acid/administration & dosage , Indomethacin/administration & dosage , Intestinal Mucosa/drug effects , Intestinal Mucosa/metabolism , Intubation, Gastrointestinal , Male , Metabolic Clearance Rate/drug effects , NG-Nitroarginine Methyl Ester/administration & dosage , Perfusion/methods , Rats , Rats, Inbred Lew , Rats, Inbred Strains
2.
Am J Physiol ; 273(5): G1077-86, 1997 11.
Article in English | MEDLINE | ID: mdl-9374705

ABSTRACT

The aim of this study was to examine the integrative response to neurokinin A (NKA) on duodenal mucosal permeability, bicarbonate secretion, fluid flux, and motility in an in situ perfusion model in anesthetized rats. Intravenous infusion of NKA (100, 200, and 400 pmol.kg-1.min-1) induced duodenal motility. Furthermore, duodenal mucosal bicarbonate secretion, fluid output, and mucosal permeability increased in response to NKA. Pretreatment with the nicotinic antagonist hexamethonium did not change the response in any of the parameters investigated, whereas the NK2-receptor antagonist MEN 10,627 effectively inhibited all responses to NKA. Indomethacin induced duodenal motility and stimulated bicarbonate secretion. In indomethacin-treated rats, NKA further increased motility but decreased indomethacin-stimulated bicarbonate secretion by 70%. The NKA-induced increase in mucosal permeability was unaltered by indomethacin. It is concluded that NKA not only induces motility but also increases mucosal permeability and fluid output. Furthermore, the neuropeptide may have both stimulative and inhibitory effects on bicarbonate secretion. All responses to NKA are dependent on NK-2 receptor activation but are not mediated through nicotinic receptors.


Subject(s)
Bicarbonates/metabolism , Duodenum/physiology , Gastrointestinal Motility/drug effects , Intestinal Mucosa/physiology , Neurokinin A/pharmacology , Animals , Chromium Radioisotopes/pharmacokinetics , Duodenum/drug effects , Edetic Acid/pharmacokinetics , Hexamethonium/pharmacology , Indomethacin/pharmacology , Infusions, Intravenous , Intestinal Mucosa/drug effects , Male , Muscle Contraction/drug effects , Muscle, Smooth/drug effects , Muscle, Smooth/physiology , Neurokinin A/administration & dosage , Peptides, Cyclic/pharmacology , Permeability , Pressure , Rats , Rats, Sprague-Dawley , Receptors, Neurokinin-2/antagonists & inhibitors , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...